Dennis Huang

Mr. Huang currently serves as Chief Technical Operations Officer at Ultragenyx where he is responsible for leading the process development, manufacturing, and supply chain distribution functions, and is a member of the executive leadership team. Mr. Huang was also Director on the Board of Directors of Bonti Inc., a privately-held biotech company focusing on botulinum toxin-based therapeutics from 2015 to its sale to Allergan in 2018. Prior to Ultragenyx, Mr. Huang was the Senior Vice President of Manufacturing and Supply Chain for InterMune and the Vice President of Biologics Manufacturing and Development for Allergan, Inc. During his 7-year tenure at Allergan he improved the commercial manufacturing performance and expanded the biologics development capability, which resulted in a rapid expansion of the biologics pipeline. Earlier in his career, Mr. Huang held several positions at Novartis, Genentech, and Synergen, where he worked in a number of roles including manufacturing, quality, and process development. Mr. Huang holds a B.A. in Chemistry from Knox College in Galesburg, Illinois.